Identification Generic Name (1S)-1-C-{(2R)-6-[(2R)-2-Butanyl]-5,10-dihydroxy-4-oxo-1,2,3,4-tetrahydro-2-anthracenyl}-5-deoxy-1-O-methyl-D-xylulose DrugBank Accession Number DB04240 Background Not Available Type Small Molecule Groups Experimental Structure 
 
 
 3D Download  MOL SDF 3D-SDF PDB SMILES InChI 
 
 
  Similar Structures Structure for (1S)-1-C-{(2R)-6-[(2R)-2-Butanyl]-5,10-dihydroxy-4-oxo-1,2,3,4-tetrahydro-2-anthracenyl}-5-deoxy-1-O-methyl-D-xylulose (DB04240) ×  Close Weight Average: 430.4908  Monoisotopic: 430.199153314  Chemical Formula C 24 H 30 O 7 Synonyms 1,2-HYDRO-1-OXY-3,4-HYDRO-3-(1-METHOXY-2-OXY-3,4-DIHYDROXYPENTYL)-8,9-DIHYDROXY-7-(SEC-BUTYL)-ANTHRACENE Pharmacology Indication Not Available Reduce drug development failure rates Build, train, & validate machine-learning models with evidence-based and structured datasets. See how     Build, train, & validate predictive machine-learning models with structured datasets. See how Contraindications & Blackbox Warnings Avoid life-threatening adverse drug events Improve clinical decision support with information on  contraindications & blackbox warnings, population restrictions, harmful risks, & more. Learn more     Avoid life-threatening adverse drug events & improve clinical decision support. Learn more Pharmacodynamics Not Available Mechanism of action Not Available Absorption Not Available Volume of distribution Not Available Protein binding Not Available Metabolism Not Available Route of elimination Not Available Half-life Not Available Clearance Not Available Adverse Effects Improve decision support & research outcomes With structured adverse effects data, including:  blackbox warnings, adverse reactions, warning & precautions, & incidence rates. Learn more     Improve decision support & research outcomes with our structured adverse effects data. Learn more Toxicity Not Available Pathways Not Available Pharmacogenomic Effects/ADRs  
 
 
 Not Available Interactions Drug Interactions  
 
 
 This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.  Not Available Food Interactions Not Available Categories Drug Categories Not Available Chemical Taxonomy Provided by  Classyfire Description This compound belongs to the class of organic compounds known as anthracenes. These are organic compounds containing a system of three linearly fused benzene rings. Kingdom Organic compounds Super Class Benzenoids Class Anthracenes Sub Class Not Available Direct Parent Anthracenes Alternative Parents Naphthols and derivatives  /  Tetralins  /  Aryl alkyl ketones  /  1-hydroxy-4-unsubstituted benzenoids  /  Monosaccharides  /  Beta-hydroxy ketones  /  Acyloins  /  Vinylogous acids  /  Alpha-hydroxy ketones  /  Secondary alcohols  /  1,2-diols  /  Dialkyl ethers  /  Organic oxides  /  Hydrocarbon derivatives 
 
 
  show 4 more Substituents 1,2-diol  /  1-hydroxy-4-unsubstituted benzenoid  /  1-naphthol  /  Acyloin  /  Alcohol  /  Alpha-hydroxy ketone  /  Anthracene  /  Aromatic homopolycyclic compound  /  Aryl alkyl ketone  /  Aryl ketone  /  Beta-hydroxy ketone  /  Carbonyl group  /  Dialkyl ether  /  Ether  /  Hydrocarbon derivative  /  Ketone  /  Monosaccharide  /  Organic oxide  /  Organic oxygen compound  /  Organooxygen compound  /  Secondary alcohol  /  Tetralin  /  Vinylogous acid 
 
 
  show 13 more Molecular Framework Aromatic homopolycyclic compounds External Descriptors Not Available Affected organisms Not Available Chemical Identifiers UNII Not Available CAS number Not Available InChI Key XGORHSPGULYMCV-HHYQQTLHSA-N InChI InChI=1S/C24H30O7/c1-5-11(2)16-7-6-13-8-14-9-15(24(31-4)23(30)20(27)12(3)25)10-17(26)18(14)22(29)19(13)21(16)28/h6-8,11-12,15,20,24-25,27-29H,5,9-10H2,1-4H3/t11-,12-,15-,20+,24+/m1/s1 IUPAC Name (3R)-7-[(2R)-butan-2-yl]-3-[(1S,3S,4R)-3,4-dihydroxy-1-methoxy-2-oxopentyl]-8,9-dihydroxy-1,2,3,4-tetrahydroanthracen-1-one SMILES CC[C@@H](C)C1=C(O)C2=C(O)C3=C(C[C@H](CC3=O)[C@H](OC)C(=O)[C@@H](O)[C@@H](C)O)C=C2C=C1 References General References Not Available External Links PubChem Compound 5288133 PubChem Substance 46504902 ChemSpider 4450362 ZINC ZINC000012504239 PDBe Ligand DXA PDB Entries 1cp8 Clinical Trials Clinical Trials  
 
 
 Phase Status Purpose Conditions Count Pharmacoeconomics Manufacturers Not Available Packagers Not Available Dosage Forms Not Available Prices Not Available Patents Not Available Properties State Solid Experimental Properties Not Available Predicted Properties Property Value Source Water Solubility 0.127 mg/mL ALOGPS logP 3.01 ALOGPS logP 3.72 Chemaxon logS -3.5 ALOGPS pKa (Strongest Acidic) 7.9 Chemaxon pKa (Strongest Basic) -3.1 Chemaxon Physiological Charge 0 Chemaxon Hydrogen Acceptor Count 7 Chemaxon Hydrogen Donor Count 4 Chemaxon Polar Surface Area 124.29 Å 2 Chemaxon Rotatable Bond Count 7 Chemaxon Refractivity 116.22 m 3 ·mol -1 Chemaxon Polarizability 46.15 Å 3 Chemaxon Number of Rings 3 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter Yes Chemaxon Veber's Rule No Chemaxon MDDR-like Rule Yes Chemaxon Predicted ADMET Features Property Value Probability Human Intestinal Absorption + 0.8894 Blood Brain Barrier - 0.7206 Caco-2 permeable + 0.5201 P-glycoprotein substrate Substrate 0.7084 P-glycoprotein inhibitor I Non-inhibitor 0.7175 P-glycoprotein inhibitor II Inhibitor 0.6555 Renal organic cation transporter Non-inhibitor 0.9175 CYP450 2C9 substrate Non-substrate 0.8073 CYP450 2D6 substrate Non-substrate 0.8346 CYP450 3A4 substrate Substrate 0.6193 CYP450 1A2 substrate Inhibitor 0.7572 CYP450 2C9 inhibitor Non-inhibitor 0.8277 CYP450 2D6 inhibitor Non-inhibitor 0.7792 CYP450 2C19 inhibitor Non-inhibitor 0.7548 CYP450 3A4 inhibitor Non-inhibitor 0.6918 CYP450 inhibitory promiscuity Low CYP Inhibitory Promiscuity 0.7438 Ames test AMES toxic 0.5139 Carcinogenicity Non-carcinogens 0.8964 Biodegradation Not ready biodegradable 0.9782 Rat acute toxicity 2.8088 LD50, mol/kg  Not applicable hERG inhibition (predictor I) Weak inhibitor 0.944 hERG inhibition (predictor II) Non-inhibitor 0.6012    ADMET data is predicted using  admetSAR , a free tool for evaluating chemical ADMET properties. ( 23092397 )  Spectra Mass Spec (NIST) Not Available Spectra Spectrum Spectrum Type Splash Key Predicted MS/MS Spectrum - 10V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 10V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Negative (Annotated) Predicted LC-MS/MS Not Available × Identify potential medication risks Easily compare up to 40 drugs with our drug interaction checker. Get severity rating, description, and management advice.  Learn more      Drug created at June 13, 2005 13:24 / Updated at June 12, 2020 16:52 